[1] Jurczak P,Groves P,Szymanska A et al.Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease[J].FEBS Lett,2016, 590(23):4192-4201
[2] Luo J,SWang LP,SHu HF et al.Cystatin CSandScardiovascularSor all-cause mortality risk in the general population: A meta-analysis[J].Clin Chim Acta,2015,23(45):39-45
[3] Vasilyeva MP,Rudenko TE2,SKutyrina IM et al.Cystatin CSis a new marker for left ventricularShypertrophySin patients with chronic kidney disease[J].Ter Arkh.2015,87(6):17-22
Zi M,Xu Y.Involvement of ystatin C nimmunity and apoptosis[J].Immunol Lett,2018,196: 80-90.
[5]Y. Xu, P. Lindemann, J. Vega-Ramos, J et al.Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system[J]. The Journal of biological chemistry,2014,2289(14): 9730-9740.
[6]李素芹,刘运宝.半胱氨酸蛋白酶抑制剂超家族与临床疾病的关系[J].海南医学,2013,24(22):3347-3350.
[7]Altuno?lu A,Erten ?,?ahin A et al.SerumScystatin CSis not an appropriate marker for kidney involvement in patients with primary Sjögren''s syndrome[J]. Int J Rheum Dis,2017,20(3):371-375
[8]Behrendt I,SPr?dzińska M,SSpodzieja M et al.Identification and characterization of antibodies elicited by humanScystatin CSfragment[J].J Mol Recognit,2018,31(4):42
[9] Targońska-Stepniak B1, Majdan M. Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients[J].Scand J Rheumatol,2011,40(5):341-346.
[10] Bäcklund A1,SHolmdahl M, Mattsson R,et al. Cystatin C nfluences the autoimmune but not inflammatory response to cartilage type II collagen leading to chronic arthritis development [J].ArthritisSRes Ther,2011,13(2):54.
[11] Hansen T,Petrow PK,J Rheumatol et al. Synovial giant cells in rheumatoid arthritis: expression of cystatin C, but not of cathepsin B[J].Exp Toxicol Pathol,2000,52(4):312-316
[12]Lertnawapan R,Bian A,Rho YH.et al.Cystatin C,renalfunction,and atherosclerosis in heumatoid arthritis[J].J Rheumatol,2011,38(11):2297-3000.
[13]Targońska-St?pniak B,Majdan M.Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis[J].Mediators Inflamm,2014,2014:1-7
[14]Yong Liu, Kai-Hong Chen, Shi-Qun Chen et al.Predictive value of post-procedural early (within 24 h) increase in cystatin C for contrast-induced acute kidney injury and mortality following coronary angiography or intervention.[J]. Oncotarget,2017 8(65):109762-109771
[15]Lertnawapan R,Bian A,Rho YH,Kawai VK et al.Cystatin C, renal function, and atheroscler -osis in rheumatoid arthritis[J]. J Rheumatol,2011,38(11):2297-300
[16]Amorim S,Campelo M,SMoura B et al.The role of biomarkers inSdilated cardiomyopathy: Assessment of clinical severity and reverse remodeling[J].Rev Port Cardiol,2017,36(10):709-716
[17] Tejera-Segura B,de Vera-González AM,López-Mejías R et al.Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis inSrheumatoid arthritis. Clin Exp Rheumatol [J].2016,34(2):230-235
[18]何姗姗,王晓燕,赵英帅.冠心病患者冠状动脉病变程度与血清胱抑素C及内皮功能相关性分析[J].重庆医学,2017,46(1):64-71
[19]刘淑卓,王建国,王淑仙等.胱抑素C在类风湿患者心脏损害中的临床应用[J].环球中医药,2013,6(S2):136-137
[20] Kang EH,Liao KP,Kim SC.Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis[J].Curr Rheumatol Rep,2018,20(7):42
|
